Photo: Coin Telegraph
(Coin Telegraph) - During a bull market, negative news is quickly digested, and the collateral damage is often limited.
Therefore, even as XRP price dumped aggressively due to the uncertainty,regarding the outcome of the United States Securities and Exchange Commission's lawsuit, other altcoins have largely been unaffected.
Crypto market data daily view. Source: Coin360
Moreover, as Bitcoin’s strong rally takes a breather, several altcoins have broken out of their overhead resistance levels and are attempting to resume their uptrend. Let’s look at a few tokens that have risen sharply in the past few days and analyze their charts to ascertain whether the rally could extend further.
ZIL/USD
Zilliqa's Zilling (ZIL) token has risen sharply in 2020. Part of the rally could be attributed to the decentralized finance boom that dominated a large portion of the year.
During the coronavirus pandemic, most people have stayed indoors and spent their time on social media. Thus, the timing of Zilliqa’s SocialPay launch could not have been better. The platform launched in May, and it rewards users for sharing Zilliqa’s updates and announcements on Twitter.
LUNA/USD
The Terra protocol’s Luna token seems to have benefitted from greater adoption of its existing products and the proposed launch of new ones. Its Chai payments app witnessed over 2.8 million transactions in November, with payment volumes crossing $90 million.
Terra is also attempting to address the product referral marketing category that mainly benefits the direct referrer. The protocol plans to officially launch BuzLink, a marketing tool, in February 2021, which will reward the entire referral chain after the sale is done.
VET/USD
The coronavirus pandemic has made people and businesses even more aware of the power of digital technology. VeChain developed the E-HCert App in collaboration with the Mediterranean Hospital of Cyprus to store COVID-19 test records.
After its successful implementation, Aretaeio Hospital has also joined the VeChain ecosystem to integrate its lab testing services, which will make the data readily accessible to patients to use as required.
Read more from the original article here.
免責事項：本記事で述べられている見解は著者の見解のみであり、Followmeの公式見解を反映するものではありません。Followmeは、提供された情報の正確性、完全性、信頼性について一切責任を負いません。また、書面で明示的に記載されている場合を除き、本記事の内容に基づいて行われたいかなる行動についても責任を負いません。
古いコメントはありません。ソファをつかむ最初のものになりましょう。